Trial Profile
A Randomized Controlled, Open-label, Multi-center Study With 104-week Saxagliptin or (and) Vitamin D3 Assessing Protective Effects on Beta Cell Function in Latent Autoimmune Diabetes in Adults (LADA) Treated With Metformin (and Insulin)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Colecalciferol (Primary) ; Saxagliptin (Primary) ; Insulin; Metformin
- Indications Latent autoimmune diabetes in adults
- Focus Therapeutic Use
- 18 Apr 2021 Status changed from recruiting to completed.
- 17 Mar 2019 Planned End Date changed from 1 Jun 2018 to 1 Jun 2021.
- 17 Mar 2019 Planned primary completion date changed from 1 Jun 2018 to 1 Dec 2020.